Publications by authors named "Adele Shields"

Claim this Profile
B
Belatacept Pharmacokinetic Analysis of Belatacept Early Steroid Withdrawal Trial (BEST) to Clinical Outcomes and Compared With Reported BENEFIT and BENEFIT-EXT Pharmacokinetic Analysis.
Alexandra Pyatt, Melissa McGowan, Ryota Tanaka, Bradley Miyagawa, Tomoyuki Mizuno, Adele Rike Shields

Clin Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations.
Nicole K Wilson, Simon Tremblay, Adele R Shields, E Steve Woodle, Rita R Alloway

Transplant Direct· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality.
Tiffany Shi, Ashley R Burg, J Timothy Caldwell, Krishna M Roskin, Cyd M Castro-Rojas, Adele R Shields

J Clin Invest· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonality.
Tiffany Shi, Ashley R Burg, J Timothy Caldwell, Krishna Roskin, Cyd M Castro-Rojas, Adele R Shields

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial.
Dixon B Kaufman, E Steve Woodle, Adele Rike Shields, John Leone, Arthur Matas

Clin J Am Soc Nephrol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection.
Alicia B Lichvar, Simon Tremblay, Abbie D Leino, Adele R Shields, Michael A Cardi

Transplantation· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection.
Cyd M Castro-Rojas, Alzbeta Godarova, Tiffany Shi, Sarah A Hummel, Adele Shields

Transplantation· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial.
E Steve Woodle, Dixon B Kaufman, Adele R Shields, John Leone, Arthur Matas

Am J Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney Transplant.
Camila Macedo, Kevin Hadi, John Walters, Beth Elinoff, Marilyn Marrari, Adele Shields

Kidney Int Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomy.
Tayyab S Diwan, Alicia B Lichvar, Abbie D Leino, Alexander A Vinks, Uwe Christians, Adele R Shields

Clin Transplant· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience.
Bassam G Abu Jawdeh, Anthony C Leonard, Yuvraj Sharma, Swapna Katipally, Adele R Shields

Front Med (Lausanne)· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
Basma Sadaka, Nicole S Ejaz, Adele R Shields, Michael A Cardi, George Wadih

Transplantation· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desensitization in kidney transplantation: review and future perspectives.
Bassam G Abu Jawdeh, Madison C Cuffy, Rita R Alloway, Adele Rike Shields, E Steve Woodle

Clin Transplant· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept.
Jill C Krisl, Rita R Alloway, Adele Rike Shields, Michael A Cardi, E Steve Woodle

Transplantation· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients.
Nicole Schmidt, Rita R Alloway, R Carlin Walsh, Basma Sadaka, Adele R Shields

Transplantation· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome inhibition for antibody-mediated allograft rejection.
Basma Sadaka, Rita R Alloway, Adele R Shields, Nicole M Schmidt, E Steve Woodle

Semin Hematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.
R Carlin Walsh, Paul Brailey, Alin Girnita, Rita R Alloway, Adele Rike Shields

Transplantation· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis